Qualitative and quantitative comparison of PET/CT and PET/MR imaging in clinical practice

Journal of Nuclear Medicine

Volumn 55, Issue 1, 2014, Pages 88-94

  Al Nabhani, Khalsa Z ^a   Syed, Rizwan ^a   Michopoulou, Sofia ^a   Alkalbani, Jokha ^a   Afaq, Asim ^a   Panagiotidis, Emmanouil ^a   O'Meara, Celia ^a   Groves, Ashley ^a   Ell, Peter ^a   Bomanji, Jamshed ^a  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

Cancer; Intraobserver agreement; PET CT; PET MR imaging

Indexed keywords

DOTATATE GA 68; FLUORINE 18; FLUORODEOXYGLUCOSE F 18; FLUOROETHYLCHOLINE F 18; GALLIUM 68; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER STAGING; CHILD; CLINICAL PRACTICE; CLINICAL PROTOCOL; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIAGNOSTIC TEST ACCURACY STUDY; DRUG TUMOR LEVEL; FEMALE; HUMAN; IMAGE QUALITY; INTERMETHOD COMPARISON; LOW ENERGY RADIATION; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL SPECIALIST; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OBSERVER VARIATION; PET SCANNER; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITATIVE DIAGNOSIS; QUALITATIVE RESEARCH; QUANTITATIVE DIAGNOSIS; QUANTITATIVE STUDY; RADIATION ATTENUATION; RADIOLOGIST; SCHOOL CHILD; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; WHOLE BODY MRI; WHOLE BODY PET; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; IMAGE PROCESSING; INTRAOBSERVER AGREEMENT; METHODOLOGY; MIDDLE AGED; MULTIMODAL IMAGING; NEOPLASM; PET/CT; PET/MR IMAGING; PILOT STUDY; POSITRON EMISSION TOMOGRAPHY; REPRODUCIBILITY; WHOLE BODY IMAGING;

CANCER; INTRAOBSERVER AGREEMENT; PET/CT; PET/MR IMAGING;

AGED; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIMODAL IMAGING; NEOPLASM STAGING; OBSERVER VARIATION; PILOT PROJECTS; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; TOMOGRAPHY, X-RAY COMPUTED; WHOLE BODY IMAGING;

EID: 84894733968     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.113.123547     Document Type: Article

References (25)

1. 18F-FDG PET/CT in head and neck tumors. Br J Cancer. 2005;92: 1046-1050.
2. Townsend DW, Beyer T, Kinahan PE, et al. The SMART scanner: a combined PET/CT tomography for clinical oncology. Nucl Sci Symp, 1998. 1998;2: 1170-1174.
3. Pichler BJ, Wehrl HF, Judenhofer MS. Latest advances in molecular imaging instrumentation. J Nucl Med. 2008;49: 5S-23S.
4. Collins CD. PET/CT in oncology: for which tumors is it the reference standard? Cancer Imaging. 2007(spec no A);7: 77-83.
5. Bomanji JB, Costa DC, Ell PJ. Clinical role of positron emission tomography in oncology. Lancet Oncol. 2001;2: 157-164.
6. Townsend DW. Dual-modality imaging: combining anatomy and function. J Nucl Med. 2008;49: 938-955.
7. Antoch G, Bockisch A. Combined PET/MRI: a new dimension in whole-body oncology imaging? Eur J Nucl Med Mol Imaging. 2009;36: S113-S120.
8. Antoch G, Vogt FM, Freudenberg LS, et al. Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology. JAMA. 2003;290: 3199-3206.
9. Müller-Horvat C, Radny P, Eigentler TK, et al. Prospective comparison of the impact on treatment decisions of whole-body magnetic resonance imaging and computed tomography in patients with metastatic malignant melanoma. Eur J Cancer. 2006;42: 342-350.
10. Smith AB, Dillon WP, Lau BC, et al. Radiation dose reduction strategy for CT protocols: successful implementation in neuroradiology section. Radiology. 2008;247: 499-506.
11. Antypas EJ, Sokhandon F, Farah M, et al. A comprehensive approach to CT radiation dose reduction: one institution's experience. AJR. 2011;197: 935-940.
12. Boellaard R. Standards for PET image acquisition and quantitative data analysis. J Nucl Med. 2009;50: 11S-20S.
13. Teräs M, Tolvanen T, Johansson JJ, Williams JJ, Knuuti J. Performance of the new generation of whole-body PET/CT scanners: Discovery STE and Discovery VCT. Eur J Nucl Med Mol Imaging. 2007;34: 1683-1692.
14. Martinez-Möller A, Souvatzoglou M, Delso G, et al. Tissue classification as a potential approach for attenuation correction in whole-body PET/MRI: evaluation with PET/CT data. J Nucl Med. 2009;50: 520-526.
15. Samarin A, Burger C, Wollenweber S, et al. PET/MR Imaging of bone lesions: implications for PET quantification from imperfect attenuation correction. Eur J Nucl Med Mol Imaging. 2012;39: 1154-1160.
16. Catana C, van der Kouwe A, Benner T, et al. Toward implementing an MRI-based PET attenuation-correction method for neurologic studies on the MR-PET brain prototype. J Nucl Med. 2010;51: 1431-1438.
17. Wagenknecht G, Kaiser H, Mottaghy F, Herzog H. MRI for attenuation correction in PET: methods and challenges. MAGMA. 2013;26: 99-113.
18. Drzezga A, Souvatzoglou M, Eiber M, et al. First clinical experience with integrated whole-body PET/MRI: comparison to PET/CT in patients with oncologic diagnoses. J Nucl Med. 2012;53: 845-855.
19. 18FFDG: standardized uptake values in normal tissues. J Nucl Med. 2004;45: 784-788.
20. Lee JW, Kim S-K, Lee SM, Moon SH, Kim T-S. Detection of hepatic metastases using dual-Time-point FDG PET/CT scans in patients with colorectal cancer. Mol Imaging Biol. 2011;13: 565-572.
21. 18F-FDG PET for the evaluation of pulmonary nodules. J Nucl Med. 2002;43: 871-875.
22. Nakamoto Y, Tamai K, Saga T, et al. Clinical value of image fusion from MR and PET in patients with head and neck cancer. Mol Imaging Biol. 2009;11: 46-53.
23. Laurent V, Trausch G, Bruot O, Oliver P, Felblinger J, Regent D. Comparative study of two whole-body imaging techniques in the case of melanoma metastases: advantages of multi-contrast MRI examination including a diffusionweighted sequences in comparison with PET/CT. Eur J Radiol. 2010;75: 376-383.
24. Khayal IS, McKnight TR, McGue C, et al. Apparent diffusion coefficient and fractional anisotropy of newly diagnosed grade II gliomas. NMR Biomed. 2009; 22: 449-455.
25. McBride DQ, Miller BL, Nikas DL, et al. Analysis of brain tumors using 1H magnetic resonance spectroscopy. Surg Neurol. 1995;44: 137-144.